Picato
Picato (ingenol mebutate) was a medication used for actinic keratosis. It was a gel that was applied directly on the skin. It has been discontinued in the United States because it's linked to higher a risk of skin cancer.
What is Picato (ingenol mebutate)?
Drug facts
Common questions about Picato (ingenol mebutate)
Picato (ingenol mebutate) is a medication used directly on the skin to treat a condition called actinic keratosis (AK). AK is where your skin cells grow faster than normal. It results from too much exposure to ultraviolet (UV) light from the sun or tanning beds. People with AK might notice symptoms such as rough and scaly patches, rough pimple-like bumps, or raised pink or gray patches on their skin. If left untreated, AK can develop into skin cancer. Picato (ingenol mebutate) works by killing the cells that form these patches or bumps, although the exact way that it does this known.
No, Picato (ingenol mebutate) has been discontinued and is no longer available in the United States.
Picato (ingenol mebutate) was discontinued by the manufacturer because it was found to potentially raise the risk of skin cancer. If you currently have Picato (ingenol mebutate), you're recommended to stop using it and contact your provider for other available treatment options.
How to save using GoodRx
Picato (ingenol mebutate) dosage
Typical dosage for Picato (ingenol mebutate)
Interactions between Picato (ingenol mebutate) and other drugs
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.